Negative Impact of Anorexia and Weight Loss During Prior Pirfenidone Administration on Subsequent Nintedanib Treatment in Patients With Idiopathic Pulmonary Fibrosis

Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Takuma Katano; Erina Tabata; Ryota Shintani; Shinko Sadoyama; Hideaki Yamakawa; Tsuneyuki Oda; Ryo Okuda; Hideya Kitamura; Tae Iwasawa; Tamiko Takemura; Takashi Ogura

Disclosures

BMC Pulm Med. 2019;19(78) 

In This Article

Conclusions

A high incidence of early termination of nintedanib was noted when patients were switched from pirfenidone. Anorexia and weight loss during prior pirfenidone treatment may increase the rate of early termination of subsequent nintedanib treatment. Further investigation is required to establish an optimal treatment strategy.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....